Summer Special! Get NewsNow Essentials at just £2.99 a month (25% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £2.99 a month (25% OFF!). Subscribe and saveSummer Special! Upgrade here at £2.99/m (25% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Novartis
Pharmaceuticals
AstraZeneca
Novo Nordisk
Sanofi
Pfizer
GSK
Eli Lilly
Teva
Johnson & Johnson
Topics

Advertisement

Novartis

Share

Top Latest Popular

Attorney General Bonta Announces $400 Million Settlement in Principle with Sandoz, a Generic Drug Manufacturer, over Conspiracy to Inflate Prices and Limit Competition California Attorney General (Press Release) 4d

California Attorney General (Press Release) 4d

3 Dividend stocks to buy for a lifetime of passive income The Motley Fool 18:34 Wed, 29 Jul

The Motley Fool 18:34 Wed, 29 Jul

Stock Watch: Why Novartis Stock Rose On Results Half As Good As J&J’s Scrip Pharma Intelligence 14:38 Tue, 28 Jul

Scrip Pharma Intelligence 14:38 Tue, 28 Jul

Advertisement

Cognizant expands Novartis partnership with agentic AI for global IT operations The Fast Mode 00:36 Tue, 28 Jul

The Fast Mode 00:36 Tue, 28 Jul

Advertisement

Natco challenges Novartis’s second patent for cancer drug ribociclib in Delhi High Court Mint 3d

Mint 3d

Cognizant bags IT operations deal from Novartis The Hindu Business Line 14:36 Tue, 28 Jul

The Hindu Business Line 14:36 Tue, 28 Jul

Advertisement

Advertisement

Latest

Wednesday

Delhi HC seeks response on Natco's patent challenge plea The Economic Times 20:41 Wed, 05 Aug

Natco challenges Novartis’s second patent for cancer drug ribociclib in Delhi High Court Mint 12:31 Wed, 05 Aug

Monday

AG Nessel Announces $400 Million Settlement in Principle with Sandoz Over Conspiracy to Inflate Prices and Limit Competition Michigan State Government (Press Release) 21:11 Mon, 03 Aug

Attorney General Bonta Announces $400 Million Settlement in Principle with Sandoz, a Generic Drug Manufacturer, over Conspiracy to Inflate Prices and Limit Competition California Attorney General (Press Release) 20:46 Mon, 03 Aug

Novartis’ Pluvicto approved by FDA for metastatic hormone-sensitive prostate cancer PMLiVE 13:20 Mon, 03 Aug

In the last month

ChrysCapital acquires controlling 70.68% stake in Novartis' India listed unit in first majority pharma investment The Times of India 12:47 Thu, 30 Jul

ChrysCapital acquires controlling 70.68% stake in Novartis India in first majority pharma investment The Times of India 11:46 Thu, 30 Jul

ChrysCapital acquires Novartis India, appoints Vikas Gupta as CEO The Business Standard 08:34 Thu, 30 Jul

PE firm ChrysCapital acquires Swiss parent’s stake in Novartis India The Hindu Business Line 04:26 Thu, 30 Jul

ChrysCapital acquires a controlling stake in Novartis India, appoints new CEO Mint 00:38 Thu, 30 Jul

Advertisement

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis